It helps improve blood sugar levels, reduce the risk of heart attack, stroke, or cardiovascular death, and lower the risk of kidney disease progression in those with T2DM and chronic kidney disease
The two biosimilars also hold the FDAs interchangeability designation, which allows them to be substituted for their reference products without a change in the patients prescription
Multivariate analysis showed that male (hazard ratio [HR] 2.27, 95%CI 1.17-4.39, P=0.013), platelet count 8.3x10 4 /l (HR 2.11, 95%CI 1.06-4.19, P=0.032) and presence of EV before BRTO (HR 2.36, 95%CI 1.06-5.27, P=0.029) were significant independent risk factors of EV worsening
Total RNA was purified and stored at 80 until use